Studies patterns of who joins scleroderma clinical trials
Looks at data on who takes part in scleroderma trials, across different groups of people.
Plain-language title generated from the registry record
Registry title: Delving Into Participation Trends of Scleroderma Clinical Trials
Key facts
- Where
- San Francisco, United StatesSee the site
Where in United States
- Power Life SciencesSan Francisco, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Power Life Sciences Inc.
- Trial code
- NCT06264492
- Record updated
- 28 February 2024
- Original description
Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics.Read full original descriptionShow less
Deciphering Patient Participation: Insights From Observational Data in Scleroderma Clinical Trials
Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics.
The study will analyze data from diverse demographic viewpoints to uncover recurring trends that could provide valuable insights for future patients with scleroderma.
Inclusion: Patient has been diagnosed with scleroderma; Patient has self-identified as planning to enroll in an observational clinical trial; Patient is a minimum of 18 years or older.
Exclusion: Patient is pregnant; Inability to perform regular electronic reporting; Patient does not understand, sign, and return consent form.